Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 89 entries
Sorted by: Best Match Show Resources per page
Retraction: CPAP for the metabolic syndrome in patients with obstructive sleep apnea. N Engl J Med 2011;365:2277-86.

The New England journal of medicine

Sharma SK, Agrawal S, Damodaran D, Sreenivas V, Kadhiravan T, Lakshmy R, Jagia P, Kumar A.
PMID: 24171540
N Engl J Med. 2013 Oct 31;369(18):1770. doi: 10.1056/NEJMc1313105.

No abstract available.

Cite
Sharma SK, Agrawal S, Damodaran D, et al. Retraction: CPAP for the metabolic syndrome in patients with obstructive sleep apnea. N Engl J Med 2011;365:2277-86. N Engl J Med. 2013;369(18):1770doi: 10.1056/NEJMc1313105.
Sharma, S. K., Agrawal, S., Damodaran, D., Sreenivas, V., Kadhiravan, T., Lakshmy, R., Jagia, P., & Kumar, A. (2013). Retraction: CPAP for the metabolic syndrome in patients with obstructive sleep apnea. N Engl J Med 2011;365:2277-86. The New England journal of medicine, 369(18), 1770. https://doi.org/10.1056/NEJMc1313105
Sharma, Surendra K, et al. "Retraction: CPAP for the metabolic syndrome in patients with obstructive sleep apnea. N Engl J Med 2011;365:2277-86." The New England journal of medicine vol. 369,18 (2013): 1770. doi: https://doi.org/10.1056/NEJMc1313105
Sharma SK, Agrawal S, Damodaran D, Sreenivas V, Kadhiravan T, Lakshmy R, Jagia P, Kumar A. Retraction: CPAP for the metabolic syndrome in patients with obstructive sleep apnea. N Engl J Med 2011;365:2277-86. N Engl J Med. 2013 Oct 31;369(18):1770. doi: 10.1056/NEJMc1313105. PMID: 24171540.
Copy Download .nbib Format: NLM
Use of Mitomycin C for Refractory Esophageal Stricture following Tracheoesophageal Fistula Repair.

European journal of pediatric surgery reports

Lakoma A, Fallon SC, Mathur S, Kim ES.
PMID: 25755944
European J Pediatr Surg Rep. 2013 Jun;1(1):24-6. doi: 10.1055/s-0033-1341418. Epub 2013 Mar 19.

Esophageal stricture is a well-described complication following tracheoesophageal fistula repair. Herein, we report two patients who had persistent esophageal strictures after several months of repeat balloon dilatations. Each patient was treated with a single application of topical mitomycin C...

Cite
Lakoma A, Fallon SC, Mathur S, et al. Use of Mitomycin C for Refractory Esophageal Stricture following Tracheoesophageal Fistula Repair. European J Pediatr Surg Rep. 2013;1(1):24-6doi: 10.1055/s-0033-1341418.
Lakoma, A., Fallon, S. C., Mathur, S., & Kim, E. S. (2013). Use of Mitomycin C for Refractory Esophageal Stricture following Tracheoesophageal Fistula Repair. European journal of pediatric surgery reports, 1(1), 24-6. https://doi.org/10.1055/s-0033-1341418
Lakoma, Anna, et al. "Use of Mitomycin C for Refractory Esophageal Stricture following Tracheoesophageal Fistula Repair." European journal of pediatric surgery reports vol. 1,1 (2013): 24-6. doi: https://doi.org/10.1055/s-0033-1341418
Lakoma A, Fallon SC, Mathur S, Kim ES. Use of Mitomycin C for Refractory Esophageal Stricture following Tracheoesophageal Fistula Repair. European J Pediatr Surg Rep. 2013 Jun;1(1):24-6. doi: 10.1055/s-0033-1341418. Epub 2013 Mar 19. PMID: 25755944; PMCID: PMC4335951.
Copy Download .nbib Format: NLM
Concentration of neuropeptide Y, galanin, &bgr;-endorphin, vasoactive intestinal peptide and gonadotropin releasing hormone in the hypothalamus of gilts during the estrous cycle.

Neuro endocrinology letters

Ziecik AJ, Okrasa S, Kalamarz H, Lakomy M, Kraeling RR.
PMID: 11458205
Neuro Endocrinol Lett. 1999;20(6):397-403.

Numerous reports indicate that peptides isolated from the brain such as beta-endorphin (beta-END), neuropeptide Y (NPY), galanin (GAL) or vasoactive intestinal peptide (VIP), modulate secretion of gonadotropins and prolactin. The objective of the present experiment was to determine concentrations...

Cite
Ziecik AJ, Okrasa S, Kalamarz H, et al. Concentration of neuropeptide Y, galanin, &bgr;-endorphin, vasoactive intestinal peptide and gonadotropin releasing hormone in the hypothalamus of gilts during the estrous cycle. Neuro Endocrinol Lett. 1999;20(6):397-403
Ziecik, A. J., Okrasa, S., Kalamarz, H., Lakomy, M., & Kraeling, R. R. (1999). Concentration of neuropeptide Y, galanin, &bgr;-endorphin, vasoactive intestinal peptide and gonadotropin releasing hormone in the hypothalamus of gilts during the estrous cycle. Neuro endocrinology letters, 20(6), 397-403.
Ziecik, Adam J., et al. "Concentration of neuropeptide Y, galanin, &bgr;-endorphin, vasoactive intestinal peptide and gonadotropin releasing hormone in the hypothalamus of gilts during the estrous cycle." Neuro endocrinology letters vol. 20,6 (1999): 397-403.
Ziecik AJ, Okrasa S, Kalamarz H, Lakomy M, Kraeling RR. Concentration of neuropeptide Y, galanin, &bgr;-endorphin, vasoactive intestinal peptide and gonadotropin releasing hormone in the hypothalamus of gilts during the estrous cycle. Neuro Endocrinol Lett. 1999;20(6):397-403. PMID: 11458205.
Copy Download .nbib Format: NLM
When one chip is not enough: augmenting the validity of SELDI-TOF proteomic profiles of clinical specimens.

Lab on a chip

Kristina G, Radomir P, Eva B, Lenka D, Radek L, Rostislav V, Borivoj V, Dalibor V.
PMID: 19294317
Lab Chip. 2009 Apr 07;9(7):1014-7. doi: 10.1039/b815503h. Epub 2009 Jan 15.

To improve recovery, selectivity and reproducibility of SELDI-TOF analyses, we found it necessary to modify manufacturer's recommended protocols on sample and chip preparation. To yield reproducible denaturing conditions we verified concentrations of denaturing, reducing and lipid-solubilizing agents. We improved...

Cite
Kristina G, Radomir P, Eva B, et al. When one chip is not enough: augmenting the validity of SELDI-TOF proteomic profiles of clinical specimens. Lab Chip. 2009;9(7):1014-7doi: 10.1039/b815503h.
Kristina, G., Radomir, P., Eva, B., Lenka, D., Radek, L., Rostislav, V., Borivoj, V., & Dalibor, V. (2009). When one chip is not enough: augmenting the validity of SELDI-TOF proteomic profiles of clinical specimens. Lab on a chip, 9(7), 1014-7. https://doi.org/10.1039/b815503h
Kristina, Greplova, et al. "When one chip is not enough: augmenting the validity of SELDI-TOF proteomic profiles of clinical specimens." Lab on a chip vol. 9,7 (2009): 1014-7. doi: https://doi.org/10.1039/b815503h
Kristina G, Radomir P, Eva B, Lenka D, Radek L, Rostislav V, Borivoj V, Dalibor V. When one chip is not enough: augmenting the validity of SELDI-TOF proteomic profiles of clinical specimens. Lab Chip. 2009 Apr 07;9(7):1014-7. doi: 10.1039/b815503h. Epub 2009 Jan 15. PMID: 19294317.
Copy Download .nbib Format: NLM
Intraspecific variation in Heterobasidion annosum for mortality rate on Pinus sylvestris and Picea abies seedlings grown in pure culture.

Mycologia

Werner A, Lakomy P.
PMID: 21156559
Mycologia. 2002 Sep-Oct;94(5):856-61.

One-month-old Scots pine (Pinus sylvestris) and Norway spruce (Picea abies) seedlings were inoculated in vitro with Heterobasidion annosum strains, four each of the P-, S- and F-intersterility groups. Variation among strains and between the IS groups in virulence, expressed...

Cite
Werner A, Lakomy P. Intraspecific variation in Heterobasidion annosum for mortality rate on Pinus sylvestris and Picea abies seedlings grown in pure culture. Mycologia. 2002;94(5):856-61
Werner, A., & Lakomy, P. (2002). Intraspecific variation in Heterobasidion annosum for mortality rate on Pinus sylvestris and Picea abies seedlings grown in pure culture. Mycologia, 94(5), 856-61.
Werner, Antoni, and Lakomy, Piotr. "Intraspecific variation in Heterobasidion annosum for mortality rate on Pinus sylvestris and Picea abies seedlings grown in pure culture." Mycologia vol. 94,5 (2002): 856-61.
Werner A, Lakomy P. Intraspecific variation in Heterobasidion annosum for mortality rate on Pinus sylvestris and Picea abies seedlings grown in pure culture. Mycologia. 2002 Sep-Oct;94(5):856-61. PMID: 21156559.
Copy Download .nbib Format: NLM
A poetic apology.

The Eugenics review

Lamy R.
PMID: 21259937
Eugen Rev. 1930 Jul;22(2):102.

No abstract available.

Cite
Lamy R. A poetic apology. Eugen Rev. 1930;22(2):102
Lamy, R. (1930). A poetic apology. The Eugenics review, 22(2), 102.
Lamy, R. "A poetic apology." The Eugenics review vol. 22,2 (1930): 102.
Lamy R. A poetic apology. Eugen Rev. 1930 Jul;22(2):102. PMID: 21259937; PMCID: PMC2984935.
Copy Download .nbib Format: NLM
880 kHz ultrasound treatment for drug delivery to the vitreous humor.

American journal of translational research

Lamy R, Chan E, Lee OT, Phone A, Salgaonkar VA, Diederich CJ, Stewart JM.
PMID: 30416658
Am J Transl Res. 2018 Oct 15;10(10):3162-3170. eCollection 2018.

Clinical management of many chronic ophthalmological disorders requires direct delivery of drugs into the vitreous. There is an important need to investigate novel needle-less alternatives to deliver drugs to the vitreous. The purpose of this study is to assess...

Cite
Lamy R, Chan E, Lee OT, et al. 880 kHz ultrasound treatment for drug delivery to the vitreous humor. Am J Transl Res. 2018;10(10):3162-3170
Lamy, R., Chan, E., Lee, O. T., Phone, A., Salgaonkar, V. A., Diederich, C. J., & Stewart, J. M. (2018). 880 kHz ultrasound treatment for drug delivery to the vitreous humor. American journal of translational research, 10(10), 3162-3170.
Lamy, Ricardo, et al. "880 kHz ultrasound treatment for drug delivery to the vitreous humor." American journal of translational research vol. 10,10 (2018): 3162-3170.
Lamy R, Chan E, Lee OT, Phone A, Salgaonkar VA, Diederich CJ, Stewart JM. 880 kHz ultrasound treatment for drug delivery to the vitreous humor. Am J Transl Res. 2018 Oct 15;10(10):3162-3170. eCollection 2018. PMID: 30416658; PMCID: PMC6220232.
Copy Download .nbib Format: NLM
Correction to: Applicability and accuracy of pretest probability calculations implemented in the NICE clinical guideline for decision making about imaging in patients with chest pain of recent onset.

European radiology

Roehle R, Wieske V, Schuetz GM, Gueret P, Andreini D, Meijboom WB, Pontone G, Garcia M, Alkadhi H, Honoris L, Hausleiter J, Bettencourt N, Zimmermann E, Leschka S, Gerber B, Rochitte C, Schoepf UJ, Shabestari AA, Nørgaard B, Sato A, Knuuti J, Meijs MFL, Brodoefel H, Jenkins SMM, Øvrehus KA, Diederichsen ACP, Hamdan A, Halvorsen BA, Rodriguez VM, Wan YL, Rixe J, Sheikh M, Langer C, Ghostine S, Martuscelli E, Niinuma H, Scholte A, Nikolaou K, Ulimoen G, Zhang Z, Mickley H, Nieman K, Kaufmann PA, Buechel RR, Herzog BA, Clouse M, Halon DA, Leipsic J, Bush D, Jakamy R, Sun K, Yang L, Johnson T, Laissy JP, Marcus R, Muraglia S, Tardif JC, Chow B, Paul N, Maintz D, Hoe J, de Roos A, Haase R, Laule M, Schlattmann P, Dewey M.
PMID: 29858635
Eur Radiol. 2018 Nov;28(11):4919-4921. doi: 10.1007/s00330-018-5521-0.

The original version of this article, published on 19 March 2018, unfortunately contained a mistake. The following correction has therefore been made in the original: The names of the authors Philipp A. Kaufmann, Ronny Ralf Buechel and Bernhard A....

Cite
Roehle R, Wieske V, Schuetz GM, et al. Correction to: Applicability and accuracy of pretest probability calculations implemented in the NICE clinical guideline for decision making about imaging in patients with chest pain of recent onset. Eur Radiol. 2018;28(11):4919-4921doi: 10.1007/s00330-018-5521-0.
Roehle, R., Wieske, V., Schuetz, G. M., Gueret, P., Andreini, D., Meijboom, W. B., Pontone, G., Garcia, M., Alkadhi, H., Honoris, L., Hausleiter, J., Bettencourt, N., Zimmermann, E., Leschka, S., Gerber, B., Rochitte, C., Schoepf, U. J., Shabestari, A. A., Nørgaard, B., Sato, A., Knuuti, J., Meijs, M. F. L., Brodoefel, H., Jenkins, S. M. M., Øvrehus, K. A., Diederichsen, A. C. P., Hamdan, A., Halvorsen, B. A., Rodriguez, V. M., Wan, Y. L., Rixe, J., Sheikh, M., Langer, C., Ghostine, S., Martuscelli, E., Niinuma, H., Scholte, A., Nikolaou, K., Ulimoen, G., Zhang, Z., Mickley, H., Nieman, K., Kaufmann, P. A., Buechel, R. R., Herzog, B. A., Clouse, M., Halon, D. A., Leipsic, J., Bush, D., Jakamy, R., Sun, K., Yang, L., Johnson, T., Laissy, J. P., Marcus, R., Muraglia, S., Tardif, J. C., Chow, B., Paul, N., Maintz, D., Hoe, J., de Roos, A., Haase, R., Laule, M., Schlattmann, P., & Dewey, M. (2018). Correction to: Applicability and accuracy of pretest probability calculations implemented in the NICE clinical guideline for decision making about imaging in patients with chest pain of recent onset. European radiology, 28(11), 4919-4921. https://doi.org/10.1007/s00330-018-5521-0
Roehle, Robert, et al. "Correction to: Applicability and accuracy of pretest probability calculations implemented in the NICE clinical guideline for decision making about imaging in patients with chest pain of recent onset." European radiology vol. 28,11 (2018): 4919-4921. doi: https://doi.org/10.1007/s00330-018-5521-0
Roehle R, Wieske V, Schuetz GM, Gueret P, Andreini D, Meijboom WB, Pontone G, Garcia M, Alkadhi H, Honoris L, Hausleiter J, Bettencourt N, Zimmermann E, Leschka S, Gerber B, Rochitte C, Schoepf UJ, Shabestari AA, Nørgaard B, Sato A, Knuuti J, Meijs MFL, Brodoefel H, Jenkins SMM, Øvrehus KA, Diederichsen ACP, Hamdan A, Halvorsen BA, Rodriguez VM, Wan YL, Rixe J, Sheikh M, Langer C, Ghostine S, Martuscelli E, Niinuma H, Scholte A, Nikolaou K, Ulimoen G, Zhang Z, Mickley H, Nieman K, Kaufmann PA, Buechel RR, Herzog BA, Clouse M, Halon DA, Leipsic J, Bush D, Jakamy R, Sun K, Yang L, Johnson T, Laissy JP, Marcus R, Muraglia S, Tardif JC, Chow B, Paul N, Maintz D, Hoe J, de Roos A, Haase R, Laule M, Schlattmann P, Dewey M. Correction to: Applicability and accuracy of pretest probability calculations implemented in the NICE clinical guideline for decision making about imaging in patients with chest pain of recent onset. Eur Radiol. 2018 Nov;28(11):4919-4921. doi: 10.1007/s00330-018-5521-0. PMID: 29858635.
Copy Download .nbib Format: NLM
Admission Vitamin D status does not predict outcome of critically ill patients on mechanical ventilation: An observational pilot study.

Indian journal of anaesthesia

Yadav S, Joshi P, Dahiya U, Baidya DK, Goswami R, Guleria R, Lakshmy R.
PMID: 29416150
Indian J Anaesth. 2018 Jan;62(1):47-52. doi: 10.4103/ija.IJA_531_17.

BACKGROUND AND AIMS: Effect of serum 25-hydroxy vitamin D (25[OH] D) levels on the recovery of critically ill mechanically ventilated patients is unclear. Hence, this study assessed 25(OH)D levels of critically ill patients on mechanical ventilation at the time...

Cite
Yadav S, Joshi P, Dahiya U, et al. Admission Vitamin D status does not predict outcome of critically ill patients on mechanical ventilation: An observational pilot study. Indian J Anaesth. 2018;62(1):47-52doi: 10.4103/ija.IJA_531_17.
Yadav, S., Joshi, P., Dahiya, U., Baidya, D. K., Goswami, R., Guleria, R., & Lakshmy, R. (2018). Admission Vitamin D status does not predict outcome of critically ill patients on mechanical ventilation: An observational pilot study. Indian journal of anaesthesia, 62(1), 47-52. https://doi.org/10.4103/ija.IJA_531_17
Yadav, Sonu, et al. "Admission Vitamin D status does not predict outcome of critically ill patients on mechanical ventilation: An observational pilot study." Indian journal of anaesthesia vol. 62,1 (2018): 47-52. doi: https://doi.org/10.4103/ija.IJA_531_17
Yadav S, Joshi P, Dahiya U, Baidya DK, Goswami R, Guleria R, Lakshmy R. Admission Vitamin D status does not predict outcome of critically ill patients on mechanical ventilation: An observational pilot study. Indian J Anaesth. 2018 Jan;62(1):47-52. doi: 10.4103/ija.IJA_531_17. PMID: 29416150; PMCID: PMC5787890.
Copy Download .nbib Format: NLM
E47 Governs the MYC-CDKN1B/p27.

Cellular and molecular gastroenterology and hepatology

Scully KM, Lahmy R, Signaevskaia L, Sasik R, Medal R, Kim H, French R, James B, Wu Y, Lowy AM, Itkin-Ansari P.
PMID: 30003124
Cell Mol Gastroenterol Hepatol. 2018 May 16;6(2):181-198. doi: 10.1016/j.jcmgh.2018.05.002. eCollection 2018.

BACKGROUND & AIMS: Oncogenic mutations in KRAS, coupled with inactivation of p53, CDKN2A/p16METHODS: RNA sequencing was used to profile E47-dependent transcriptomes in 5 PDA cell lines. Gene Ontology analysis identified cell-cycle control as the most altered pathway. Small interfering...

Cite
Scully KM, Lahmy R, Signaevskaia L, et al. E47 Governs the MYC-CDKN1B/p27. Cell Mol Gastroenterol Hepatol. 2018;6(2):181-198doi: 10.1016/j.jcmgh.2018.05.002.
Scully, K. M., Lahmy, R., Signaevskaia, L., Sasik, R., Medal, R., Kim, H., French, R., James, B., Wu, Y., Lowy, A. M., & Itkin-Ansari, P. (2018). E47 Governs the MYC-CDKN1B/p27. Cellular and molecular gastroenterology and hepatology, 6(2), 181-198. https://doi.org/10.1016/j.jcmgh.2018.05.002
Scully, Kathleen M, et al. "E47 Governs the MYC-CDKN1B/p27." Cellular and molecular gastroenterology and hepatology vol. 6,2 (2018): 181-198. doi: https://doi.org/10.1016/j.jcmgh.2018.05.002
Scully KM, Lahmy R, Signaevskaia L, Sasik R, Medal R, Kim H, French R, James B, Wu Y, Lowy AM, Itkin-Ansari P. E47 Governs the MYC-CDKN1B/p27. Cell Mol Gastroenterol Hepatol. 2018 May 16;6(2):181-198. doi: 10.1016/j.jcmgh.2018.05.002. eCollection 2018. PMID: 30003124; PMCID: PMC6039985.
Copy Download .nbib Format: NLM
Breast Radiation Therapy-Related Treatment Outcomes in Patients With or Without Germline Mutations on Multigene Panel Testing.

International journal of radiation oncology, biology, physics

Chapman BV, Liu D, Shen Y, Olamigoke OO, Lakomy DS, Barrera AMG, Stecklein SR, Sawakuchi GO, Bright SJ, Bedrosian I, Litton JK, Smith BD, Woodward WA, Perkins GH, Hoffman KE, Stauder MC, Strom EA, Arun BK, Shaitelman SF.
PMID: 34582940
Int J Radiat Oncol Biol Phys. 2022 Feb 01;112(2):437-444. doi: 10.1016/j.ijrobp.2021.09.026. Epub 2021 Sep 25.

PURPOSE: Multigene panel testing has increased the detection of germline mutations in patients with breast cancer. The implications of using radiation therapy (RT) to treat patients with pathogenic variant (PV) mutations are not well understood and have been studied...

Cite
Chapman BV, Liu D, Shen Y, et al. Breast Radiation Therapy-Related Treatment Outcomes in Patients With or Without Germline Mutations on Multigene Panel Testing. Int J Radiat Oncol Biol Phys. 2021;112(2):437-444doi: 10.1016/j.ijrobp.2021.09.026.
Chapman, B. V., Liu, D., Shen, Y., Olamigoke, O. O., Lakomy, D. S., Barrera, A. M. G., Stecklein, S. R., Sawakuchi, G. O., Bright, S. J., Bedrosian, I., Litton, J. K., Smith, B. D., Woodward, W. A., Perkins, G. H., Hoffman, K. E., Stauder, M. C., Strom, E. A., Arun, B. K., & Shaitelman, S. F. (2022). Breast Radiation Therapy-Related Treatment Outcomes in Patients With or Without Germline Mutations on Multigene Panel Testing. International journal of radiation oncology, biology, physics, 112(2), 437-444. https://doi.org/10.1016/j.ijrobp.2021.09.026
Chapman, Bhavana V, et al. "Breast Radiation Therapy-Related Treatment Outcomes in Patients With or Without Germline Mutations on Multigene Panel Testing." International journal of radiation oncology, biology, physics vol. 112,2 (2022): 437-444. doi: https://doi.org/10.1016/j.ijrobp.2021.09.026
Chapman BV, Liu D, Shen Y, Olamigoke OO, Lakomy DS, Barrera AMG, Stecklein SR, Sawakuchi GO, Bright SJ, Bedrosian I, Litton JK, Smith BD, Woodward WA, Perkins GH, Hoffman KE, Stauder MC, Strom EA, Arun BK, Shaitelman SF. Breast Radiation Therapy-Related Treatment Outcomes in Patients With or Without Germline Mutations on Multigene Panel Testing. Int J Radiat Oncol Biol Phys. 2022 Feb 01;112(2):437-444. doi: 10.1016/j.ijrobp.2021.09.026. Epub 2021 Sep 25. PMID: 34582940.
Copy Download .nbib Format: NLM
Oncological outcomes of surgery for isolated retroperitoneal recurrence in renal cancer patients after radical nephrectomy.

Urologic oncology

Staník M, Poprach A, Littnerová S, Čapák I, Hulová M, Šebová N, Lakomý R, Jarkovský J, Doležel J.
PMID: 34961683
Urol Oncol. 2021 Dec 24; doi: 10.1016/j.urolonc.2021.11.028. Epub 2021 Dec 24.

AIMS: Isolated retroperitoneal recurrence (IRR) in renal cancer patients after radical nephrectomy (RN) is a rare event and poses a therapeutic dilemma. We evaluated oncologic outcomes in surgically treated patients with IRR and established prognostic factors associated with survival....

Cite
Staník M, Poprach A, Littnerová S, et al. Oncological outcomes of surgery for isolated retroperitoneal recurrence in renal cancer patients after radical nephrectomy. Urol Oncol. 2021;doi: 10.1016/j.urolonc.2021.11.028.
Staník, M., Poprach, A., Littnerová, S., Čapák, I., Hulová, M., Šebová, N., Lakomý, R., Jarkovský, J., & Doležel, J. (2021). Oncological outcomes of surgery for isolated retroperitoneal recurrence in renal cancer patients after radical nephrectomy. Urologic oncology, . https://doi.org/10.1016/j.urolonc.2021.11.028
Staník, Michal, et al. "Oncological outcomes of surgery for isolated retroperitoneal recurrence in renal cancer patients after radical nephrectomy." Urologic oncology vol. (2021). doi: https://doi.org/10.1016/j.urolonc.2021.11.028
Staník M, Poprach A, Littnerová S, Čapák I, Hulová M, Šebová N, Lakomý R, Jarkovský J, Doležel J. Oncological outcomes of surgery for isolated retroperitoneal recurrence in renal cancer patients after radical nephrectomy. Urol Oncol. 2021 Dec 24; doi: 10.1016/j.urolonc.2021.11.028. Epub 2021 Dec 24. PMID: 34961683.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 89 entries